Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand

References 

1. Associate Minister of Health, Minister of Health . Medicines New Zealand: Contributing to Good Health Outcomes for All New Zealanders. Wellington: Ministry of Health; 2007;[Internet Site]. [cited 2009 Aug 25]. Available at: http://www.moh.govt.nz/moh.nsf/pagesmh/7236/$File/medicines-nz.pdf
2. Glover J, Hetzel D, Tennant S. Australia and New Zealand, Health Systems of International Encyclopedia of Public Health. Oxford: Academic Press; 2008;255–267
3. Pharmaceutical Management Agency . Information Sheets—Introduction to PHARMAC. Wellington: PHARMAC; 2009 Jul 27;[Internet Site]. [cited 2009 Aug 25]. Available at: http://pharmac.govt.nz/2008/12/16/01_PHARM_Infsheet_INTRO.pdf
4. Williams G, Poynton M. PHARMAC Lecture—Professional Pharmacy Studies. [Pharmacy 409] Auckland, New Zealand: The University of Auckland; May 5, 2009;
5. Morgan S, Boothe K. Prescription drug subsidies in Australia and New Zealand. Aust Prescr. 2010;33:2–4
6. Morgan S, Henley G, McMahon M, Barer M. Influencing drug prices through formulary-based policies: lessons from New Zealand. Healthc Policy. 2007;3:1–20
7. McCormack P, Quigley J, Hansen P. Review of Access to High-Cost, Highly-Specialised Medicines in New Zealand. Report Presented to Minister of Health. Available at: http://www.beehive.govt.nz/sites/all/files/Review%20of%20Access%20to%20High%20Cost%20Highly%20Specialised%20Medicines%2031%20April%202010.pdfAccessed 28.05.10
8. Ryall T. Health Minister confirms new medicines spending, 30th July 2009. Available at: http://www.beehive.govt.nz/release/health+minister+confirms+new+medicines+spendingAccessed 13.06.10
9. PHARMAC . Pharmaceutical Management Agency Annual Review, New Zealand Government. Available at: http://www.pharmac.govt.nz/2007/11/21/ARev071.pdf2007;Accessed 15.09.09
10. Kanavos P. Do generics offer significant savings to the UK National Health Service?. Curr Med Res Opin. 2007;23:105–116
    • CrossRef
11. King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43:462–469
    • MEDLINE
12. Generic medicines, basic notions: European Generic Medicines Association. Available at: http://www.egagenerics.com/gen-basics.htmAccessed 15.06.10
13. IMS . IMS health data 2003. Available at: http://www.imshealth.com2003;
14. Generic Prescribing . Association of British Pharmaceutical Industry. BSC/5/99/3k. Available at: http://www.kidney.org.uk/main/switch_meds/generic.pdfAccessed 16.06.10
15. Lofgran H. Generic medicines in Australia: business dynamics and recent policy reform. South Med Rev. 2009;2:24–28Available at: http://apps.who.int/medicinedocs/documents/s16383e/s16383e.pdfAccessed 17.05.10
16. Matching US Generic Drug Use Would Save Canada $1.6-Billion, Toronto, April 6, 2010. Available at: http://www.canadiangenerics.ca/en/news/apr_06_10.aspAccessed 18.05.10
17. Medsafe . 6.3 ed.. New Zealand Regulatory Guidelines for Medicines. Vol. 1. Wellington: Medsafe; 2009;[cited 2009 Jul 8]. Available at: http://medsafe.govt.nz/regulatory/Guideline/Full%20-%20NZ%20Regulatory%20Guidelines%20for%20Medicines.pdfAccessed 24.06.10
18. Borgheini G. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs. Clin Ther. 2003;25:1578–1592
    • Abstract
    • Full-Text PDF (1169 KB)
    • CrossRef
19. Cumming J, Mayes N, Daube J. How New Zealand has contained expenditures on drugs. BMJ. 2010;340:1224–1227
20. Upfront: Brand Change . Changing to a generic drug. BPac NZ. [cited 1 May 2008]. Available at: http://www.bpac.org.nz/magazine/2007/june/upfront.asp2007;Accessed 15.05.10
21. Kalisch L, Roughead E, Gilbert A. Pharmaceutical brand substitution in Australia—are there multiple switches per prescription?. Aust N Z J Public Health. 2007;31:348–352
    • CrossRef
22. Minutes of the PHARMAC Consumer Advisory Committee (CAC) Meeting, Friday 13 July 2007. Available at: http://www.pharmac.govt.nz/pdf/021007a.pdfAccessed 13.02.10
23. Generic medicines: dealing with multiple brands. National Prescribing Service Newsletter. Australia. Available at: http://www.nps.org.au/health_professionals/publications/nps_news/current/generic_medicines_dealing_with_multiple_brands2007;Accessed 16.06.10
24. Babar ZU, Stewart J, Reddy S, et al. An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland. [Online first]. Available at: http://www.springerlink.com/content/2n22020r2x366782/?p=ed9bd33d6e5347b49bc417ad89486317&pi=1Accessed 28/6/2010
25. Why you should prescribe generically. Best Pract Gen. 2008;14:24–27Available at: http://www.bpac.org.nz/magazine/2008/june/generic.aspAccessed 26.06.10
26. Pharmaceutical Management Agency . Information Sheets—The Truth About Generic Medicines. [Internet Site]. [cited 2009 August 25]. Available at: http://pharmac.govt.nz/2008/12/16/07_PHARM_Infosheets_GENERIC_MEDS.pdfAccessed 27.07.09
27. Mott D, Cline R. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care. 2002;40(8):662–674
    • MEDLINE
    • CrossRef
28. Medsafe, Minister of Health . Eltroxin—Medsafe Summary Review of Eltroxin (Media Conference Information). Wellington: Medsafe; 2008 Sep 11;[Internet Site]. [cited 2009 May 23]. Available at: http://www.medsafe.govt.nz/hot/MediaContents.aspAccessed 25.06.10
29. Ford N, t’Hoen E. Generic medicines are not substandard medicines. Lancet. 2002;359:1351–1352
    • Full Text
    • Full-Text PDF (39 KB)
    • CrossRef
30. Kjoenniksen I, Lindbaek M, Granas A. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28:284–289
    • MEDLINE
    • CrossRef
31. Mason J, Bearden W. Generic drugs: consumer, pharmacist and physician perceptions of the issues. J Consum Aff. 1980;14:193–206
32. Bearden W, Mason J. Physician and pharmacist perceptions of generic drugs. Ind Market Manag. 1979;8(1):63–68
33. Medsafe . Regulatory Issues—No Immediate Changes to Generics. [Internet Site]. [cited 2009 May 23]. Available at: http://medsafe.govt.nz/profs/RIss/gensubleg.aspAccessed 15.05.10
34. Maling T. Finding a better balance between pharmaceutical supply and demand—a medicinal issue. N Z Fam Phys. 2002;29:3
35. Perkins E, Dovey S, Tilyard M, Boyle K, & Penrose A. A 30 change management strategy to modify ACE-inhibitor prescribing. RNZCGP Research Unit; 1999.
36. Babar Z, Awaisu A. Evaluating community pharmacists’ perceptions and practices on generic medicines: a pilot study from Peninsular Malaysia. J Generic Med. 2008;5:315–330
37. Hassali A, Stewart K. Quality use of generic medicines. Aust Prescr. 2004;27:80–81Available at: http://www.australianprescriber.com/upload/pdf/articles/488.pdfAccessed 26.06.10
38. SSRI antidepressants and brand changing. Best Pract J. March 2007;27:Special edition. Available at: http://www.bpac.org.nz/magazine/2007/march/changing.asp#ssriAccessed 20.06.10
39. Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharm Pract. 2008;6:93–97
40. Request for proposal (RFP) supply of market services research (medication brand changes). Pharm Manag Agency N Z. Jan 2008;25th:
41. Smith FJ. Research Methods in Pharmacy Practice. Pharmaceutical Press; 2002;1–286
42. Pharmacy Guild of New Zealand . About the Pharmacy Guild—Facts at a Glance. Wellington: Pharmacy Guild of New Zealand; 2006;[Internet Site]. Available at: http://www.pgnz.org.nz/about-us/Accessed 26.06.10
43. In:  Sinclair N editors. Generics Survey. Pharmacy Today. Auckland: CMPMedica (NZ) Ltd; 2009, Jul;5
44. Scahill S, Harrison J, Sheridan J. The ABC of New Zealand’s Ten Year Vision for pharmacists: awareness, barriers and consultation. Int J Pharm Pract. 2009;17:135–142
    • CrossRef
45. Pharmacy Council of New Zealand . Workforce Demographics as at 30th June 2009. Available at: http://www.pharmacycouncil.org.nz/cms_show_download.php?id=125Accessed 20.06.10
46. Allenet B, Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci. 2003;25:197–202
    • MEDLINE
    • CrossRef
47. Tatley M. Monitoring of generic medicines and brand changes. BPJ Spec Ed Generics. 2009;18–20Available at: http://www.bpac.org.nz/magazine/2009/generics/generics.asp?article=6Accessed 26.05.10
48. New Zealand Pharmacovigilance Centre—CARM . CARM Background Information. Dunedin: CARM; 2009 Sep;[Internet Site]. [cited 2009 Sep 15]. Available at: http://carm.otago.ac.nz/index.asp?link=carmAccessed 19.06.10
49. Lamy PP. Generic equivalents: issues and concerns. J Clin Pharmacol. 1986;26:309–316
50. Al-Gedadi N, Azmi Hassali M. Pharmacists’ views on generic medicines: a review of the literature. J Generic Med. 2008;5:209–218
51. Barrett LL, AARP Knowledge Management . Pharmacists’ Attitudes and Practices Regarding Generic Drugs. Washington: AARP; 2005 Sep;[Serial on the Internet]. [cited 2009 Aug 18]. Available at: http://www.aarp.org/researchAccessed 27.06.10
52. Kirking DM, Gaither CA, Ascione FJ, Welage LS. Physicians individual and organizational views on generic medications. J Am Pharm Assoc. 2001;41:718–722
53. Meredith PA. Generic drugs—therapeutic equivalence. Drug Saf. 1996;15:233–242
    • MEDLINE
    • CrossRef
54. Medsafe . Interchangeable Status (IMM). [Internet Site]. [cited 2009 Sep 23]. Available at: http://medsafe.govt.nz/profs/imm.aspAccessed 07.07.06
55. Purvis L, AARP Public Policy Institute . Strategies to Increase Generic Drug Utilization and Associated Savings. Washington: AARP; 2008 Dec;[Serial on the Internet]. [cited 2009 Aug 18]. Available at: http://assets.aarp.org/rgcenter/health/i16_generics.pdfAccessed 15.06.10
56. Banahan BF, Kolaassa EM. Generic Substitution and Narrow Therapeutic Index Drugs—A National Survey of Retail and Hospital Pharmacies. Oxford, Mississippi: University of Mississippi; 1994;
57. Pharmacist claiming, Media Release. Available at: http://www.moh.govt.nz/moh.nsf/pagesmh/5284?OpenAccessed 22.06.10